v2.3.0.15
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Cash flow from operating activities:  
Net loss$ (6,927,652)$ (4,787,637)
Adjustments to reconcile net loss to net cash used in operating activities:  
Amortization of contingent note payable and note discounts400,498258,449
Amortization of debt premiums(284,061) 
Depreciation and patent amortization47,035160,083
Allowance for doubtful accounts3,724(26,724)
Reserve for inventory 185,938
Loss on extinguishment of debt2,227,437 
Loss on settlement of debt and beneficial conversion granted 1,058,262
Adjustment to conversion price to induce conversion to equity258,328 
Change in fair value of derivative instruments(1,439,082)(932,624)
Derivative liabilities related to convertible notes 1,723,269
Incremental derivative liabilities958,065 
Stock based compensation2,583,2091,095,814
Contingent compensation payable15,88625,000
Changes in operating assets and liabilities:  
Accounts receivable(80,248)(8,188)
Inventory and inventory deposit(39,190)103,287
Prepaid expenses and other assets12,950(20,477)
Accounts payable and accrued expenses383,790281,054
Accrued interest payable501,253230,757
Deferred revenue(21,550) 
Net cash used in operating activities(1,015,288)(653,737)
Cash flow used in investing activities:  
Purchase of fixed assets(16,040)(12,132)
Net cash used in investing activities(16,040)(12,132)
Cash flow from financing activities:  
Proceeds from promissory notes payable805,000 
Payments on promissory notes payable(75,000)(88,743)
Proceeds from related party advances and notes payable 6,000
Payment on related party notes payable (5,000)
Proceeds from convertible promissory notes135,000670,000
Obligation to issue common stock15,000(5,000)
Proceeds from exercise of warrants22 
Proceeds from issuance of common stock and warrants155,00078,200
Net cash provided by financing activities1,035,022655,457
Net increase (decrease) in cash3,694(10,412)
Cash and cash equivalents at beginning of period15,92411,357
Cash and cash equivalents at end of period19,618945
Supplemental disclosures:  
Cash paid for interest50,1563,196
Cash paid for income taxes  
Non-cash financing activities:  
Conversion of convertible debentures to common stock338,500125,000
Captilization of accrued interest into new debt114,900 
Common stock and warrants issued as debt discount150,327 
Cancellation of shares upon issuance of convertible notes (200,000)
Warrants issued for release of collateral | Cancellation of warrants
  
Changes in operating assets and liabilities:  
Issuance of Stock and Warrants for Services or Claims27,000 
Common Stock | Extensions of Debt
  
Changes in operating assets and liabilities:  
Issuance of Stock and Warrants for Services or Claims357,320 
Cancellation of warrants
  
Non-cash financing activities:  
Common stock issued 68,000
Deferred financing fees
  
Non-cash financing activities:  
Common stock issued117,589 
Trade payables
  
Non-cash financing activities:  
Common stock issued259,800 
Interest Expense
  
Non-cash financing activities:  
Common stock issued$ 173,721$ 8,550